The Iowa Board of Pharmacy has recommended that Cannabidiol (CBD) be reclassified as a Schedule II substance in Iowa. The board met this week to hear a request from Carl Olsen, a cannabis advocate from Des Moines, who urged Iowa to reschedule cannabis itself. While the board wasn’t comfortable accepting marijuana as a plant with accepted medical benefits at this time, they unanimously agreed that CBD should be reclassified.
CBD is one of many active cannabinoids in marijuana. It is believed to effectively treat many seizure disorders, particularly in children, and is also known to help those suffering from inflammation and chronic pain.
While we would have preferred to see Iowa reschedule cannabis itself, we’re still glad they’re taking steps toward positive cannabis policy. The recommendation now rests with the state legislature who must vote to approve it.